Tag: patent cliff

November 21, 2017

3 Top Biotech Stocks that Pay Dividends

Payouts are becoming more popular in the sector, which means income investors may want to give biotech stocks another look.
January 3, 2017

Top Biotech Trends for 2017

No doubt about it—2016 was a tumultuous year for biotech. But that doesn’t mean you should be afraid of this...
December 12, 2016

Pharmaceutical Outlook 2017: Seeking a Competitive Edge

One thing’s clear: if pharmaceutical companies want to remain profitable, they’ll need to tweak their business strategy in 2017.
December 8, 2016

How Personalized Medicine Can Change Your Investment Strategy

Pharmaceutical companies have developed numerous strategies to counter the patent cliff. One such tactic? Capitalizing on the personalized medicine market....
October 31, 2016

Do Generic Drugs Make the Cut?

Once a drug patent expires, a generic drug company can manufacture a generic bioequivalent. What does that mean for consumers?...
April 25, 2016

Nutraceutical Industry Overview

A nutraceutical industry overview – a look at what is shaping the market.
October 2, 2015

AstraZeneca is a Stock to Watch in 2016

According to Motley Fool, a pharmaceutical patent cliff is poised to set in next year. AstraZeneca's (NUSE:AZN) current efforts to...